[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2019 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Jun-2019 [#2]
Profit Trend
QoQ- -26.34%
YoY- 25.75%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 3,279,684 2,820,530 2,806,462 2,775,996 3,144,432 2,384,956 2,384,416 23.65%
PBT 123,520 -191,865 62,145 85,448 120,972 70,220 77,706 36.16%
Tax -33,860 42,418 -23,097 -27,628 -42,380 -26,990 -26,160 18.74%
NP 89,660 -149,447 39,048 57,820 78,592 43,230 51,546 44.58%
-
NP to SH 89,596 -149,219 39,172 57,796 78,468 42,468 50,708 46.10%
-
Tax Rate 27.41% - 37.17% 32.33% 35.03% 38.44% 33.67% -
Total Cost 3,190,024 2,969,977 2,767,414 2,718,176 3,065,840 2,341,726 2,332,869 23.17%
-
Net Worth 350,047 336,573 516,387 518,564 528,825 509,862 522,618 -23.42%
Dividend
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Div 62,695 22,177 29,557 44,299 62,521 41,621 48,535 18.59%
Div Payout % 69.98% 0.00% 75.46% 76.65% 79.68% 98.01% 95.71% -
Equity
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Net Worth 350,047 336,573 516,387 518,564 528,825 509,862 522,618 -23.42%
NOSH 261,229 261,229 261,229 261,229 260,505 260,505 260,505 0.18%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 2.73% -5.30% 1.39% 2.08% 2.50% 1.81% 2.16% -
ROE 25.60% -44.33% 7.59% 11.15% 14.84% 8.33% 9.70% -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 1,255.48 1,081.04 1,076.09 1,065.29 1,207.05 916.82 917.05 23.27%
EPS 34.28 -57.19 15.01 22.18 30.12 16.33 19.51 45.55%
DPS 24.00 8.50 11.33 17.00 24.00 16.00 18.67 18.20%
NAPS 1.34 1.29 1.98 1.99 2.03 1.96 2.01 -23.66%
Adjusted Per Share Value based on latest NOSH - 261,229
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 227.56 195.70 194.73 192.61 218.18 165.48 165.44 23.65%
EPS 6.22 -10.35 2.72 4.01 5.44 2.95 3.52 46.11%
DPS 4.35 1.54 2.05 3.07 4.34 2.89 3.37 18.53%
NAPS 0.2429 0.2335 0.3583 0.3598 0.3669 0.3538 0.3626 -23.42%
Price Multiplier on Financial Quarter End Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 -
Price 1.26 2.06 2.44 2.84 2.27 2.78 2.89 -
P/RPS 0.10 0.19 0.23 0.27 0.19 0.30 0.32 -53.91%
P/EPS 3.67 -3.60 16.25 12.80 7.54 17.03 14.82 -60.53%
EY 27.22 -27.76 6.16 7.81 13.27 5.87 6.75 153.13%
DY 19.05 4.13 4.64 5.99 10.57 5.76 6.46 105.50%
P/NAPS 0.94 1.60 1.23 1.43 1.12 1.42 1.44 -24.72%
Price Multiplier on Announcement Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 19/11/18 -
Price 1.88 2.04 2.21 2.66 2.36 2.76 3.09 -
P/RPS 0.15 0.19 0.21 0.25 0.20 0.30 0.34 -42.01%
P/EPS 5.48 -3.57 14.71 11.99 7.83 16.91 15.84 -50.68%
EY 18.24 -28.04 6.80 8.34 12.76 5.92 6.31 102.79%
DY 12.77 4.17 5.13 6.39 10.17 5.80 6.04 64.65%
P/NAPS 1.40 1.58 1.12 1.34 1.16 1.41 1.54 -6.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment